Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context

Molecular Cancer

Volumn 7, Issue , 2008, Pages

  Monticone, Massimiliano ^a   Biollo, Emanuela ^b   Maffei, Massimo ^c   Donadini, Alessandra ^c   Romeo, Francesco ^c   Storlazzi, Clelia Tiziana ^d   Giaretti, Walter ^c   Castagnola, Patrizio ^c  

^a CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; B RAF KINASE; GLUTAMIC ACID; GLYCINE; INTERLEUKIN 8; K RAS PROTEIN; TUMOR MARKER; VALINE; BRAF PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; MESSENGER RNA; ONCOPROTEIN; RAS PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL ADHESION; CELL CLONE; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN ASSEMBLY AND DISASSEMBLY; COLORECTAL CANCER; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MICROSATELLITE MARKER; MUTATIONAL ANALYSIS; NEOVASCULARIZATION (PATHOLOGY); NITROGEN METABOLISM; PHENOTYPE; PREDICTION; PROGNOSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; GENETICS; METABOLISM; MUTATION; TUMOR CELL LINE;

CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUTATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; RNA, MESSENGER;

EID: 58149508236     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-7-92     Document Type: Article

References (84)

1. Vogelstein B Fearon ER Hamilton SR Kern SE Preisinger AC Leppert M Nakamura Y White R Smits AM Bos JL Genetic alterations during colorectal-tumor development N Engl J Med 1988, 319:525-532 2841597
2. Kambara T Simms LA Whitehall VL Spring KJ Wynter CV Walsh MD Barker MA Arnold S McGivern A Matsubara N et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum Gut 2004, 53:1137-1144 1774130 15247181 10.1136/gut.2003.037671
3. McGivern A Wynter CV Whitehall VL Kambara T Spring KJ Walsh MD Barker MA Arnold S Simms LA Leggett BA et al. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer Fam Cancer 2004, 3:101-107 10.1023/ B:FAME.0000039861.30651.c8 15340260
4. Jass JR Baker K Zlobec I Higuchi T Barker M Buchanan D Young J Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: Concept of a 'fusion' pathway to colorectal cancer Histopathology 2006, 49:121-131 1619718 16879389 10.1111/j.1365-2559.2006.02466.x
5. Kranenburg O The KRAS oncogene: Past, present, and future Biochim Biophys Acta 2005, 1756:81-82 16269215
6. Kern SE Fearon ER Tersmette KW Enterline JP Leppert M Nakamura Y White R Vogelstein B Hamilton SR Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected] JAMA 1989, 261:3099-3103 10.1001/jama.261.21.3099 2654431
7. Benhattar J Losi L Chaubert P Givel JC Costa J Prognostic significance of K-ras mutations in colorectal carcinoma Gastroenterology 1993, 104:1044-1048 8462792
8. Andreyev HJ Norman AR Cunningham D Oates J Dix BR Iacopetta BJ Young J Walsh T Ward R Hawkins N et al. Kirsten ras mutations in patients with colorectal cancer: The 'RASCAL II' study Br J Cancer 2001, 85:692-696 10.1054/bjoc.2001.1964 11531254
9. Oliveira C Westra JL Arango D Ollikainen M Domingo E Ferreira A Velho S Niessen R Lagerstedt K Alhopuro P et al. Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status Hum Mol Genet 2004, 13:2303-2311 10.1093/hmg/ddh238 15294875
10. Gibbs JB Sigal IS Poe M Scolnick EM Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules Proc Natl Acad Sci USA 1984, 81:5704-5708 391779 6148751 10.1073/pnas.81.18.5704
11. Chang F Lee JT Navolanic PM Steelman LS Shelton JG Blalock WL Franklin RA McCubrey JA Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: A target for cancer chemotherapy Leukemia 2003, 17:590-603 10.1038/sj.leu.2402824 12646949
12. McCubrey JA Steelman LS Chappell WH Abrams SL Wong EW Chang F Lehmann B Terrian DM Milella M Tafuri A et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance Biochim Biophys Acta 2007, 1773:1263-1284 10.1016/j.bbamcr.2006.10.001 17126425
13. Guerra C Mijimolle N Dhawahir A Dubus P Barradas M Serrano M Campuzano V Barbacid M Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context Cancer Cell 2003, 4:111-120 10.1016/ S1535-6108(03)00191-0 12957286
14. Keller JW Franklin JL Graves-Deal R Friedman DB Whitwell CW Coffey RJ Oncogenic KRAS provides a uniquely powerful and variable oncogenic contribution among RAS family members in the colonic epithelium J Cell Physiol 2007, 210:740-749 10.1002/jcp.20898 17133351
15. Tuveson DA Shaw AT Willis NA Silver DP Jackson EL Chang S Mercer KL Grochow R Hock H Crowley D et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects Cancer Cell 2004, 5:375-387 10.1016/S1535-6108(04)00085-6 15093544
16. Castagnola P Giaretti W Mutant KRAS, chromosomal instability and prognosis in colorectal cancer Biochim Biophys Acta 2005, 1756:115-125 16112461
17. Lievre A Bachet JB Le Corre D Boige V Landi B Emile JF Cote JF Tomasic G Penna C Ducreux M et al. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer Cancer Res 2006, 66:3992-3995 10.1158/0008-5472.CAN-06-0191 16618717
18. Yuen ST Davies H Chan TL Ho JW Bignell GR Cox C Stephens P Edkins S Tsui WW Chan AS et al. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia Cancer Res 2002, 62:6451-6455 12438234
19. Oliveira C Pinto M Duval A Brennetot C Domingo E Espin E Armengol M Yamamoto H Hamelin R Seruca R Schwartz S Jr BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency Oncogene 2003, 22:9192-9196 10.1038/sj.onc.1207061 14668801
20. Wang L Cunningham JM Winters JL Guenther JC French AJ Boardman LA Burgart LJ McDonnell SK Schaid DJ Thibodeau SN BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair Cancer Res 2003, 63:5209-5212 14500346
21. Fransen K Klintenas M Osterstrom A Dimberg J Monstein HJ Soderkvist P Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas Carcinogenesis 2004, 25:527-533 10.1093/carcin/bgh049 14688025
22. Oliveira C Velho S Domingo E Preto A Hofstra RM Hamelin R Yamamoto H Seruca R Schwartz S Jr Concomitant RASSF1A hypermethylation and KRAS/ BRAF mutations occur preferentially in MSI sporadic colorectal cancer Oncogene 2005, 24:7630-7634 10.1038/sj.onc.1208906 16007118
23. Rajagopalan H Bardelli A Lengauer C Kinzler KW Vogelstein B Velculescu VE Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status Nature 2002, 418:934 10.1038/418934a 12198537
24. Chan TL Zhao W Leung SY Yuen ST BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas Cancer Res 2003, 63:4878-4881 12941809
25. Ikehara N Semba S Sakashita M Aoyama N Kasuga M Yokozaki H BRAF mutation associated with dysregulation of apoptosis in human colorectal neoplasms Int J Cancer 2005, 115:943-950 10.1002/ijc.20957 15729718
26. Calistri D Rengucci C Seymour I Lattuneddu A Polifemo AM Monti F Saragoni L Amadori D Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression J Cell Physiol 2005, 204:484-488 10.1002/ jcp.20310 15702478
27. Ahlquist T Bottillo I Danielsen SA Meling GI Rognum TO Lind GE Dallapiccola B Lothe RA RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A Neoplasia 2008, 10:680-686 682 p following 686 2434205 18592002
28. Oliveira C Velho S Moutinho C Ferreira A Preto A Domingo E Capelinha AF Duval A Hamelin R Machado JC et al. KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression Oncogene 2007, 26:158-163 10.1038/ sj.onc.1209758 16953233
29. Suter CM Norrie M Ku SL Cheong KF Tomlinson I Ward RL CpG island methylation is a common finding in colorectal cancer cell lines Br J Cancer 2003, 88:413-419 10.1038/sj.bjc.6600699 12569385
30. Davies H Bignell GR Cox C Stephens P Edkins S Clegg S Teague J Woffendin H Garnett MJ Bottomley W et al. Mutations of the BRAF gene in human cancer Nature 2002, 417:949-954 10.1038/nature00766 12068308
31. Hosack DA Dennis G Jr Sherman BT Lane HC Lempicki RA Identifying biological themes within lists of genes with EASE Genome Biol 2003, 4:R70 328459 14519205 10.1186/gb-2003-4-10-r70
32. Mitsutake N Knauf JA Mitsutake S Mesa C Jr Zhang L Fagin JA Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells Cancer Res 2005, 65:2465- 2473 10.1158/0008-5472.CAN-04-3314 15781663
33. Costa AM Herrero A Fresno MF Heymann J Alvarez JA Cameselle-Teijeiro J Garcia-Rostan G BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma Clin Endocrinol (Oxf) 2008, 68:618-634 10.1111/j.1365-2265.2007.03077.x 18070147
34. Heng HH Stevens JB Lawrenson L Liu G Ye KJ Bremer SW Ye CJ Patterns of genome dynamics and cancer evolution Cell Oncol 2008, 30:513-514 18936532
35. Sparmann A Bar-Sagi D Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis Cancer Cell 2004, 6:447-458 10.1016/j.ccr.2004.09.028 15542429
36. Rubie C Frick VO Pfeil S Wagner M Kollmar O Kopp B Graber S Rau BM Schilling MK Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer World J Gastroenterol 2007, 13:4996-5002 17854143
37. Cacev T Radosevic S Krizanac S Kapitanovic S Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression Carcinogenesis 2008, 29:1572-1580 10.1093/carcin/bgn164 18628251
38. Jiang W Li X Rao S Wang L Du L Li C Wu C Wang H Wang Y Yang B Constructing disease-specific gene networks using pair-wise relevance metric: Application to colon cancer identifies interleukin 8, desmin and enolase 1 as the central elements BMC Syst Biol 2008, 2:72 2535780 18691435 10.1186/1752-0509-2-72
39. Al-Mulla F Milner-White EJ Going JJ Birnie GD Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression J Pathol 1999, 187:433-438 10.1002/ (SICI)1096-9896(199903)187:4<433::AID-PATH273>3.0.CO;2-E 10398103
40. Al-Mulla F MacKenzie EM Differences in in vitro invasive capacity induced by differences in Ki-Ras protein mutations J Pathol 2001, 195:549-556 10.1002/path.995 11745690
41. Giaretti W Rapallo A Geido E Sciutto A Merlo F Risio M Rossini FP Specific K-ras2 mutations in human sporadic colorectal adenomas are associated with DNA near-diploid aneuploidy and inhibition of proliferation Am J Pathol 1998, 153:1201-1209 1853049 9777951
42. Tai IT Dai M Owen DA Chen LB Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy J Clin Invest 2005, 115:1492-1502 1090471 15902309 10.1172/ JCI23002
43. Yang E Kang HJ Koh KH Rhee H Kim NK Kim H Frequent inactivation of SPARC by promoter hypermethylation in colon cancers Int J Cancer 2007, 121:567-575 10.1002/ijc.22706 17397030
44. Duncan LM Deeds J Cronin FE Donovan M Sober AJ Kauffman M McCarthy JJ Melastatin expression and prognosis in cutaneous malignant melanoma J Clin Oncol 2001, 19:568-576 11208852
45. Prislei S Mozzetti S Filippetti F De Donato M Raspaglio G Cicchillitti L Scambia G Ferlini C From plasma membrane to cytoskeleton: A novel function for semaphorin 6A Mol Cancer Ther 2008, 7:233-241 10.1158/ 1535-7163.MCT-07-0390 18187809
46. Dhanabal M Wu F Alvarez E McQueeney KD Jeffers M MacDougall J Boldog FL Hackett C Shenoy S Khramtsov N et al. Recombinant semaphorin 6A-1 ectodomain inhibits in vivo growth factor and tumor cell line-induced angiogenesis Cancer Biol Ther 2005, 4:659-668 10.1158/ 1535-7163.MCT-04-0290 15917651
47. Paus E Myklebust AT Expression and interconversion of neuron-specific enolase in patient sera and extracts from small-cell lung cancer cells Tumour Biol 1996, 17:271-280 8792853
48. Chen C Chen LQ Yang GL Li Y Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases Ai Zheng 2007, 26:1221-1226 17991322
49. He S Yaung J Kim YH Barron E Ryan SJ Hinton DR Endoplasmic reticulum stress induced by oxidative stress in retinal pigment epithelial cells Graefes Arch Clin Exp Ophthalmol 2008, 246:677-683 10.1007/ s00417-008-0770-2 18278507
50. Brush MH Weiser DC Shenolikar S Growth arrest and DNA damage-inducible protein GADD34 targets protein phosphatase 1 alpha to the endoplasmic reticulum and promotes dephosphorylation of the alpha subunit of eukaryotic translation initiation factor 2 Mol Cell Biol 2003, 23:1292-1303 141149 12556489 10.1128/MCB.23.4.1292-1303.2003
51. Powolny A Takahashi K Hopkins RG Loo G Induction of GADD gene expression by phenethylisothiocyanate in human colon adenocarcinoma cells J Cell Biochem 2003, 90:1128-1139 10.1002/jcb.10733 14635187
52. Budanov AV Shoshani T Faerman A Zelin E Kamer I Kalinski H Gorodin S Fishman A Chajut A Einat P et al. Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability Oncogene 2002, 21:6017-6031 10.1038/sj.onc.1205877 12203114
53. Joy Espiritu D Mazzone T Oxidative stress regulates adipocyte apolipoprotein E and suppresses its expression in obesity Diabetes 2008, 57(11):2992-2998 10.2337/db08-0592 18678613
54. Li J Holbrook NJ Elevated gadd153/chop expression and enhanced c-Jun N-terminal protein kinase activation sensitizes aged cells to ER stress Exp Gerontol 2004, 39:735-744 10.1016/j.exger.2004.02.008 15130668
55. Corradetti MN Inoki K Guan KL The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway J Biol Chem 2005, 280:9769-9772 10.1074/jbc.C400557200 15632201
56. Pan Y Chen H Siu F Kilberg MS Amino acid deprivation and endoplasmic reticulum stress induce expression of multiple activating transcription factor-3 mRNA species that, when overexpressed in HepG2 cells, modulate transcription by the human asparagine synthetase promoter J Biol Chem 2003, 278:38402-38412 10.1074/jbc.M304574200 12881527
57. Lee JI Dominy JE Jr Sikalidis AK Hirschberger LL Wang W Stipanuk MH HepG2/C3A cells respond to cysteine deprivation by induction of the amino acid deprivation/integrated stress response pathway Physiol Genomics 2008, 33:218-229 10.1152/physiolgenomics.00263.2007 18285520
58. Curthoys NP Gstraunthaler G Mechanism of increased renal gene expression during metabolic acidosis Am J Physiol Renal Physiol 2001, 281:F381-390 11502586
59. Sieger KA Mhashilkar AM Stewart A Sutton RB Strube RW Chen SY Pataer A Swisher SG Grimm EA Ramesh R Chada S The tumor suppressor activity of MDA-7/IL-24 is mediated by intracellular protein expression in NSCLC cells Mol Ther 2004, 9:355-367 10.1016/j.ymthe.2003.11.014 15006602
60. Huang EY Madireddi MT Gopalkrishnan RV Leszczyniecka M Su Z Lebedeva IV Kang D Jiang H Lin JJ Alexandre D et al. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties Oncogene 2001, 20:7051-7063 10.1038/ sj.onc.1204897 11704829
61. Denoyelle C Abou-Rjaily G Bezrookove V Verhaegen M Johnson TM Fullen DR Pointer JN Gruber SB Su LD Nikiforov MA et al. Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway Nat Cell Biol 2006, 8:1053-1063 10.1038/ncb1471 16964246
62. Stanhill A Levin V Hendel A Shachar I Kazanov D Arber N Kaminski N Engelberg D Ha-ras(val12) induces HSP70b transcription via the HSE/HSF1 system, but HSP70b expression is suppressed in Ha-ras(val12)-transformed cells Oncogene 2006, 25:1485-1495 10.1038/sj.onc.1209193 16278678
63. Fuchs D Berges C Opelz G Daniel V Naujokat C HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway Biochem Biophys Res Commun 2008, 374:309-314 10.1016/j.bbrc.2008.07.012 18625202
64. Mo H Elson CE Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention Exp Biol Med (Maywood) 2004, 229:567-585 15229351
65. Park HJ Zhang Y Georgescu SP Johnson KL Kong D Galper JB Human umbilical vein endothelial cells and human dermal microvascular endothelial cells offer new insights into the relationship between lipid metabolism and angiogenesis Stem Cell Rev 2006, 2:93-102 17237547
66. Di Stasi D Vallacchi V Campi V Ranzani T Daniotti M Chiodini E Fiorentini S Greeve I Prinetti A Rivoltini L et al. DHCR24 gene expression is upregulated in melanoma metastases and associated to resistance to oxidative stress-induced apoptosis Int J Cancer 2005, 115:224-230 10.1002/ijc.20885 15688385
67. Wang Y Li X Wang L Ding P Zhang Y Han W Ma D An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression J Cell Sci 2004, 117:1525-1532 10.1242/jcs.00994 15020679
68. Spanjaard RA Whren KM Graves C Bhawan J Tumor necrosis factor receptor superfamily member TROY is a novel melanoma biomarker and potential therapeutic target Int J Cancer 2007, 120:1304-1310 10.1002/ijc.22367 17187358
69. Lever MA Th'ng JP Sun X Hendzel MJ Rapid exchange of histone H1.1 on chromatin in living human cells Nature 2000, 408:873-876 10.1038/ 35048603 11130728
70. Blewitt ME Gendrel AV Pang Z Sparrow DB Whitelaw N Craig JM Apedaile A Hilton DJ Dunwoodie SL Brockdorff N et al. SmcHD1, containing a structural-maintenance-of-chromosomes hinge domain, has a critical role in X inactivation Nat Genet 2008, 40:663-669 10.1038/ng.142 18425126
71. Wu Q Zhang T Cheng JF Kim Y Grimwood J Schmutz J Dickson M Noonan JP Zhang MQ Myers RM Maniatis T Comparative DNA sequence analysis of mouse and human protocadherin gene clusters Genome Res 2001, 11:389-404 311048 11230163 10.1101/gr.167301
72. Frese KK Latorre IJ Chung SH Caruana G Bernstein A Jones SN Donehower LA Justice MJ Garner CC Javier RT Oncogenic function for the Dlg1 mammalian homolog of the Drosophila discs-large tumor suppressor EMBO J 2006, 25:1406-1417 1422156 16511562 10.1038/sj.emboj.7601030
73. Bullard B Ferguson C Minajeva A Leake MC Gautel M Labeit D Ding L Labeit S Horwitz J Leonard KR Linke WA Association of the chaperone alphaB-crystallin with titin in heart muscle J Biol Chem 2004, 279:7917-7924 10.1074/jbc.M307473200 14676215
74. Westendorf JJ The formin/diaphanous-related protein, FHOS, interacts with Rac1 and activates transcription from the serum response element J Biol Chem 2001, 276:46453-46459 10.1074/jbc.M105162200 11590143
75. Naslavsky N Caplan S C-terminal EH-domain-containing proteins: Consensus for a role in endocytic trafficking, EH? J Cell Sci 2005, 118:4093-4101 10.1242/jcs.02595 16155252
76. Lo M Ling V Wang YZ Gout PW The xc-cystine/glutamate antiporter: A mediator of pancreatic cancer growth with a role in drug resistance Br J Cancer 2008, 99:464-472 10.1038/sj.bjc.6604485 18648370
77. Arrigo AP Paul C Ducasse C Sauvageot O Kretz-Remy C Small stress proteins: Modulation of intracellular redox state and protection against oxidative stress Prog Mol Subcell Biol 2002, 28:171-184 11908058
78. Wyttenbach A Sauvageot O Carmichael J Diaz-Latoud C Arrigo AP Rubinsztein DC Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin Hum Mol Genet 2002, 11:1137-1151 10.1093/hmg/11.9.1137 11978772
79. Yu K Ganesan K Tan LK Laban M Wu J Zhao XD Li H Leung CH Zhu Y Wei CL et al. A precisely regulated gene expression cassette potently modulates metastasis and survival in multiple solid cancers PLoS Genet 2008, 4:e1000129 2444049 18636107 10.1371/journal.pgen.1000129
80. Klostermann A Lutz B Gertler F Behl C The orthologous human and murine semaphorin 6A-1 proteins (SEMA6A-1/Sema6A-1) bind to the enabled/ vasodilator-stimulated phosphoprotein-like protein (EVL) via a novel carboxyl-terminal zyxin-like domain J Biol Chem 2000, 275:39647-39653 10.1074/jbc.M006316200 10993894
81. Irizarry RA Hobbs B Collin F Beazer-Barclay YD Antonellis KJ Scherf U Speed TP Exploration, normalization, and summaries of high density oligonucleotide array probe level data Biostatistics 2003, 4:249-264 10.1093/biostatistics/4.2.249 12925520
82. Saeed AI Sharov V White J Li J Liang W Bhagabati N Braisted J Klapa M Currier T Thiagarajan M et al. TM4: A free, open-source system for microarray data management and analysis Biotechniques 2003, 34:374-378 12613259
83. Tusher VG Tibshirani R Chu G Significance analysis of microarrays applied to the ionizing radiation response Proc Natl Acad Sci USA 2001, 98:5116-5121 33173 11309499 10.1073/pnas.091062498
84. Eisen MB Spellman PT Brown PO Botstein D Cluster analysis and display of genome-wide expression patterns Proc Natl Acad Sci USA 1998, 95:14863-14868 24541 9843981 10.1073/pnas.95.25.14863